OPSENS: HEALTH CANADA APPROVAL FOR THE SALE OF OPTOWIRE II
22 June 2016Quebec City, Quebec, June 22, 2016 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) today announced receipt of Health Canada approval to sell the OptoWire II in Canada. The OptoWire II is an optical guidewire developed to measure Fractional Flow Reserve (“FFR“). FFR measurement is used for the diagnostic of the severity of coronary…